Cargando…
Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome
BACKGROUND: Serum adiponectin circulates in three multimeric isoforms: high-molecular-weight (HMW), middle-molecular-weight (MMW), and low-molecular-weight (LMW) isoforms. Potential change in the circulating adiponectin levels in patients with nephrotic syndrome (NS) remain unknown. This study aimed...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357647/ https://www.ncbi.nlm.nih.gov/pubmed/34061287 http://dx.doi.org/10.1007/s10157-021-02085-w |
_version_ | 1783737174484582400 |
---|---|
author | Tamai, Tetsuro Kamijo, Kaori Abe, Yoshifusa Hibino, Satoshi Sakurai, Shunsuke Watanabe, Shuichiro Watanabe, Yoshitaka Nimura, Satomi Shiratori, Atsutoshi Takayanagi, Takaaki Watanabe, Tsuneki Nakano, Yuya Ikeda, Hirokazu Dobashi, Kazushige Nakano, Yasuko Mizuno, Katsumi Itabashi, Kazuo |
author_facet | Tamai, Tetsuro Kamijo, Kaori Abe, Yoshifusa Hibino, Satoshi Sakurai, Shunsuke Watanabe, Shuichiro Watanabe, Yoshitaka Nimura, Satomi Shiratori, Atsutoshi Takayanagi, Takaaki Watanabe, Tsuneki Nakano, Yuya Ikeda, Hirokazu Dobashi, Kazushige Nakano, Yasuko Mizuno, Katsumi Itabashi, Kazuo |
author_sort | Tamai, Tetsuro |
collection | PubMed |
description | BACKGROUND: Serum adiponectin circulates in three multimeric isoforms: high-molecular-weight (HMW), middle-molecular-weight (MMW), and low-molecular-weight (LMW) isoforms. Potential change in the circulating adiponectin levels in patients with nephrotic syndrome (NS) remain unknown. This study aimed to assess the levels of total adiponectin and the distribution of its isoforms in pediatric patients with NS. METHODS: We sequentially measured total adiponectin and each adiponectin isoform levels at the onset of NS, initial remission, and during the remission period of the disease in 31 NS patients. We also calculated the ratios of HMW (%HMW), MMW (%MMW), and LMW (%LMW) to total adiponectin incuding 51 control subjects. RESULTS: The median of total serum adiponectin levels in patients were 36.7, 36.7, and 20.2 μg/mL at the onset, at initial remission, and during the remission period of NS, respectively. These values were significantly higher than those in control subjects. The median values of %HMW, %MMW, and %LMW values were 56.9/27.0/14.1 at the onset, 62.0/21.8/13.4 at the initial remission, and 58.1/21.7/17.5 at during the remission period of NS, respectively. Compared with control subjects, %HMW at initial remission and %MMW at the onset were high, and the %LMW values at the onset and at initial remission were low. CONCLUSIONS: In patients with NS, total serum adiponectin levels increase at the onset of the disease, and the ratio of adiponectin isoforms changes during the course of the disease. Further studies are needed to delineate the mechanisms between proteinuria and adiponectin isoforms change. |
format | Online Article Text |
id | pubmed-8357647 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-83576472021-08-30 Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome Tamai, Tetsuro Kamijo, Kaori Abe, Yoshifusa Hibino, Satoshi Sakurai, Shunsuke Watanabe, Shuichiro Watanabe, Yoshitaka Nimura, Satomi Shiratori, Atsutoshi Takayanagi, Takaaki Watanabe, Tsuneki Nakano, Yuya Ikeda, Hirokazu Dobashi, Kazushige Nakano, Yasuko Mizuno, Katsumi Itabashi, Kazuo Clin Exp Nephrol Original Article BACKGROUND: Serum adiponectin circulates in three multimeric isoforms: high-molecular-weight (HMW), middle-molecular-weight (MMW), and low-molecular-weight (LMW) isoforms. Potential change in the circulating adiponectin levels in patients with nephrotic syndrome (NS) remain unknown. This study aimed to assess the levels of total adiponectin and the distribution of its isoforms in pediatric patients with NS. METHODS: We sequentially measured total adiponectin and each adiponectin isoform levels at the onset of NS, initial remission, and during the remission period of the disease in 31 NS patients. We also calculated the ratios of HMW (%HMW), MMW (%MMW), and LMW (%LMW) to total adiponectin incuding 51 control subjects. RESULTS: The median of total serum adiponectin levels in patients were 36.7, 36.7, and 20.2 μg/mL at the onset, at initial remission, and during the remission period of NS, respectively. These values were significantly higher than those in control subjects. The median values of %HMW, %MMW, and %LMW values were 56.9/27.0/14.1 at the onset, 62.0/21.8/13.4 at the initial remission, and 58.1/21.7/17.5 at during the remission period of NS, respectively. Compared with control subjects, %HMW at initial remission and %MMW at the onset were high, and the %LMW values at the onset and at initial remission were low. CONCLUSIONS: In patients with NS, total serum adiponectin levels increase at the onset of the disease, and the ratio of adiponectin isoforms changes during the course of the disease. Further studies are needed to delineate the mechanisms between proteinuria and adiponectin isoforms change. Springer Singapore 2021-06-01 2021 /pmc/articles/PMC8357647/ /pubmed/34061287 http://dx.doi.org/10.1007/s10157-021-02085-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Tamai, Tetsuro Kamijo, Kaori Abe, Yoshifusa Hibino, Satoshi Sakurai, Shunsuke Watanabe, Shuichiro Watanabe, Yoshitaka Nimura, Satomi Shiratori, Atsutoshi Takayanagi, Takaaki Watanabe, Tsuneki Nakano, Yuya Ikeda, Hirokazu Dobashi, Kazushige Nakano, Yasuko Mizuno, Katsumi Itabashi, Kazuo Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome |
title | Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome |
title_full | Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome |
title_fullStr | Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome |
title_full_unstemmed | Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome |
title_short | Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome |
title_sort | distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357647/ https://www.ncbi.nlm.nih.gov/pubmed/34061287 http://dx.doi.org/10.1007/s10157-021-02085-w |
work_keys_str_mv | AT tamaitetsuro distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT kamijokaori distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT abeyoshifusa distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT hibinosatoshi distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT sakuraishunsuke distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT watanabeshuichiro distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT watanabeyoshitaka distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT nimurasatomi distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT shiratoriatsutoshi distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT takayanagitakaaki distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT watanabetsuneki distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT nakanoyuya distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT ikedahirokazu distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT dobashikazushige distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT nakanoyasuko distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT mizunokatsumi distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome AT itabashikazuo distributionofserumadiponectinisoformsinpediatricpatientswithsteroidsensitivenephroticsyndrome |